
AbL Diagnostics SA
PAR:ABLD

Intrinsic Value
The intrinsic value of one
ABLD
stock under the Base Case scenario is
1.09
EUR.
Compared to the current market price of 5.15 EUR,
AbL Diagnostics SA
is
Overvalued by 79%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
AbL Diagnostics SA
Fundamental Analysis


Revenue & Expenses Breakdown
AbL Diagnostics SA
Balance Sheet Decomposition
AbL Diagnostics SA
Current Assets | 10.2m |
Cash & Short-Term Investments | 1.7m |
Receivables | 3.8m |
Other Current Assets | 4.8m |
Non-Current Assets | 3.3m |
PP&E | 463.8k |
Intangibles | 2.6m |
Other Non-Current Assets | 235.2k |
Free Cash Flow Analysis
AbL Diagnostics SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
AbL Diagnostics SA
Revenue
|
5.9m
EUR
|
Operating Expenses
|
-6.4m
EUR
|
Operating Income
|
-505.4k
EUR
|
Other Expenses
|
690.1k
EUR
|
Net Income
|
184.7k
EUR
|
ABLD Profitability Score
Profitability Due Diligence
AbL Diagnostics SA's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Score
AbL Diagnostics SA's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
ABLD Solvency Score
Solvency Due Diligence
AbL Diagnostics SA's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Score
AbL Diagnostics SA's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ABLD Price Targets Summary
AbL Diagnostics SA
According to Wall Street analysts, the average 1-year price target for
ABLD
is 6.28 EUR
with a low forecast of 6.22 EUR and a high forecast of 6.47 EUR.
Dividends
Current shareholder yield for ABLD is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ABLD
stock under the Base Case scenario is
1.09
EUR.
Compared to the current market price of 5.15 EUR,
AbL Diagnostics SA
is
Overvalued by 79%.